Incyte Corporation
Biotechnology
Healthcare
INCY
199 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
84.75
52 week high
86.96
high
85.83
52 week low
0.00
low
84.43
growth
28.60 %
previous Close
84.73
P/E ratio
54
market cap
14.98 B
div yield
0
usd
Jun 2025
qoq
revenue
1.22 B
15.45 %
net incoming
405 M
156.00 %
eps
1.57 %
35.34 %
eps surprise
12.14 %
net profit margin
33.32 %
18.00 %
operating incoming
530 M
158.48 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
78.75 M
7.59 %
top top